INTRODUCTION
The perichondrium is a connective tissue that supports the growth of cartilage. Several studies have shown that a perichondrial graft enhances cartilage repair and growth at anatomical locations including joints, the nasal septum, the larynx, and the ear [1, 2] . The activity of chondrocytes is regulated by glycosaminoglycans and hyaluronic acid (HA), which enhance the secretion and synthesis of proteoglycans [3, 4] . HA regenerates cartilage through mesenchymal signalling via fibrosis and scarring. The mechanisms underlying these processes include the inhibition of macrophage motility, the stimulation of lymphocyte migration and proliferation and granulocyte degranulation and phagocytosis [5] .
Histones are alkaline proteins present in all eukaryotic cells. Histone deacetylase (HDAC) inhibitors preserve the acetylated state of histone and thereby alter gene expression; in turn, they thereby alter cellular migration, apoptosis, differentiation, and proliferation [6] as well as cellular functions such as fibrosis and angiogenesis [7, 8] . The beneficial effects of HDAC inhibition in the therapeutic management of neurodegeneration, myelofibrosis, malignancy, and cystic fibrosis has been reported [9] . HDAC has also been implicated in cartilage regeneration and in chondrocyte hypertrophy [10] . Among the effects of the HDAC inhibitor trichostatin A (TCA) are accelerated embryonic development, increased stem cell differentiation, and potent anti-inflammatory and anti-cancer property activities [11] [12] [13] [14] [15] . TCA also enhances wound repair by increasing the acetylation of lysine in keratinocytes located at the wound site [16] . Based on these observations, the present study evaluated the chondrogenic effect of TCA in rabbit recipients of a perichondrial graft.
EXPERIMENTAL Animals
The donor and recipient animals in this study were 2-month-old New Zealand rabbits (800 -1200 g). They were kept under standard laboratory conditions at room temperature (20-25 °C) with a 12: 12-h light : dark cycle. The rabbits were allowed to acclimate to the lab for 10 days before the start of the experiment. The protocols used in this study were approved by the Animal Ethical Committee of Tongji Medical College, Huazhong University of Science and Technology, China (no. TJM/ 2015/ 14) and the given study followed the guidelines of Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC) for experimentation and animal use [17] .
Graft collection and implantation
The rabbits were separated into three groups of 12 each according to the different durations of treatment: 2, 4, 6 and 8 weeks. Surgery was performed in rabbits anaesthetised by an intramuscular injection of xylazine (5 mg/kg) and ketamine (35 mg/kg) followed by the prophylactic intramuscular injection of cefuroxime at a dose of 30 mg/kg. The skin of the rabbits was sterilised before the operation, which began with a superficial incision of the ear skin. The skin was then withdrawn and a 20 × 20mm 2 fragment of perichondrium was excised from its bed. The wound was sutured close using 5/0 braided polyglactin. The graft was then sutured into place on the paravertebal muscle of the face of each rabbit using monofilament polypropylene (6/0), ensuring that the graft was kept in a stretched position but without tension. The rabbits were separated into three groups: a non-treated control group, a vehicle-treated control group that received 0.3 mL of saline, and a TCA-treated group administered 0.3 mL of TCA (500 ng/mL). TCA and saline were injected beneath the perichondrial graft. Polyglactin sutures of 5/0 were used to close the recipient site.
Histopathological study
Neochondrogenesis by the perichondrial graft was evaluated histologically 2, 4, 6 and 8 weeks after surgery. At each time point, rabbits from the different groups were euthanised, and tissue specimens were excised from the operative site. The specimens were fixed in 10 % formalin, dehydrated in a graded series of ethanol, and paraffin-embedded. Tissue sections of 10 mm thickness, prepared using a microtome, were stained with haematoxylin and eosin (H & E) and Masson's trichrome. Light microscopy (400 ×) was used to evaluate the histology of the perichondrial graft according to the cellular content and cartilage thickness. The latter was measured at 10 different points using an ocular micrometer and the mean value was calculated. The pathologist evaluating the histology sections had no prior information about the treatment.
Statistical analysis
The results are expressed as mean ± standard deviations (n = 12). The data were analysed by a one-way ANOVA followed by Dunnett's post-hoc test. P < 0.05 was considered to indicate statistical significance.
RESULTS

Effect of TCA on cartilage growth
Neocartilage development was not observed in either the control or the vehicle-treated group after 2 post-operative weeks, whereas immature cartilage was detected at the perichondrial graft site in the TCA treated group. At 4 and 6 weeks after surgery, the neocartilage development in the TCA-treated group increased further. Signs of inflammation and infection were not seen in any of the groups. In the two control groups, the chondrocytes were smaller and pyknotic, lacked vacuoles, and were sparsely distributed, whereas the cells were spherical and contained cytoplasmic vacuoles in the TCA treated group (Figure 1) .
After 8 weeks, mature chondrochytes were seen in all three groups, but the cartilage in both control groups was much thinner than the cartilage of the TCA group (Figure 2) .
Effect of TCA on cartilage thickness
The thickness of the cartilage in the TCA-treated rabbits 8 weeks after perichondrial transplantation was 905 mm, whereas it was 632 and 639 mm in the non-treated and vehicletreated control groups, respectively. The difference between the TCA group and both control groups was significant (p < 0.01), whereas the difference between the two controls was not.
DISCUSSION
Cartilage replacement is an essential aspect of orthopaedic, maxillofacial, and plastic surgery. The advantages of perichondrial grafting in the treatment of cartilage defects have been demonstrated in several experimental and clinical studies. The factors that promote cartilaginous differentiation from the perichondrium have also been examined [2] . The role of HDAC in cartilage regeneration and differentiation was previously described [18] . HDAC inhibitors alter extracellular matrix expression to promote cartilage growth by enhancing proteoglycan synthesis [19] . The HDAC inhibitor, TCA, enhances wound repair by increasing the acetylation of lysine in wound keratinocytes [16] .TCA also accelerates embryonic development and stem cell differentiation in addition to possessing strong anti-inflammatory and anti-cancer properties [11] [12] [13] [14] [15] . Among its mechanisms of action is a decrease in the expression of the metalloproteinase enzyme and the inhibition of cytokine stimulation. In our study, TCA was topically applied to the region of the perichondrial graft. TCA-stimulated neochondrogenesis was then determined by histological examination of cartilage tissue sections. Several compounds that promote chondrocyte differentiation and enhance graft thickness have been shown to stimulate cartilage regeneration in perichondrial grafts [20] . In this study, topical application of TCA significantly (p < 0.01) increased the thickness of the cartilage associated with the perichondrial graft compared to the control groups. Histological analysis of the TCA-treated graft showed increased neochondrogenesis.
Further investigations are needed to determine the optimal dose of TCA in cartilage regeneration and to examine possible side effects. Additional studies are also needed to assess the roles of the various factors that participate in modulating the TCA-induced cartilage regeneration process.
CONCLUSION
Topical application of the HDAC inhibitor TCA enhances chondrocyte proliferation and differentiation and, thus, neochondrogenesis from a perichondrial graft. Furthermore, the findings of this study will be useful in understanding the role of trichostatin A in renal disease conditions. 
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